{"organizations": [], "uuid": "7b3568227aedf967e861caca51c333d3e0280aa2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.npr.org", "main_image": "", "site_section": "http://www.npr.org/rss/rss.php?id=1012", "section_title": "Politics : NPR", "url": "http://www.npr.org/2015/10/08/446980186/tpp-negotiators-reached-agreement-with-sticky-compromise-on-biologics-drugs", "country": "US", "title": "TPP Negotiators Reached Agreement With Sticky Compromise On Biologics Drugs", "performance_score": 1, "site": "npr.org", "participants_count": 2, "title_full": "TPP Negotiators Reached Agreement With Sticky Compromise On Biologics Drugs : NPR", "spam_score": 0.0, "site_type": "news", "published": "2015-10-09T00:35:00.000+03:00", "replies_count": 1, "uuid": "9a4d100107f7a86ef7d75f98a92c94eadaa5971d"}, "author": "All Things Considered", "url": "http://www.npr.org/2015/10/08/446980186/tpp-negotiators-reached-agreement-with-sticky-compromise-on-biologics-drugs#post-0", "ord_in_thread": 0, "title": "TPP Negotiators Reached Agreement With Sticky Compromise On Biologics Drugs", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "A big sticking point in the negotiations over the Trans-Pacific Partnership involved biologics medicines and vaccines created from living organisms. The dispute centered on patent protection: how many years drug companies should have before facing competition from generics. The negotiators ended up with a complicated compromise that gives drug makers five to eight years of protection. But nobody is really happy with the outcome.", "external_links": [], "published": "2015-10-09T00:35:00.000+03:00", "crawled": "2015-10-09T00:22:39.379+03:00", "highlightTitle": ""}